Literature DB >> 18312891

Post-Katrina: study in crisis-related program adaptability.

Colin D Pero1, Anna M Pou, Moises A Arriaga, Daniel W Nuss.   

Abstract

OBJECTIVE: To discuss disaster planning, didactic reorganization, and clinical realignments useful in rebuilding academic otolaryngology residency programs after disaster.
SUMMARY: We describe our reorganization and analysis of objective measures in resident education before and after Hurricane Katrina. Post-Katrina, the number of full-time faculty and part-time clinical instructors/gratis faculty has decreased (4 vs 9 and 36 vs 43, respectively), but the number of part-time LSU faculty (private-academic partnership) has increased (0 vs 3) with overall improved resident supervision. Resident complement decreased by 9.3%. Surgical case loads are essentially unchanged. Reorganization of the didactic schedule has increased attendance and maintained examination scores above national averages. Establishment of two new practice sites provided an adequate number of patients for residency training.
CONCLUSION: Poststorm reorganization has maintained or exceeded pre-Katrina performance standards. Establishment of communication and data retrieval proved irreplaceable and demand advance preparation.

Entities:  

Mesh:

Year:  2008        PMID: 18312891     DOI: 10.1016/j.otohns.2007.12.006

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Finding Focus in Crisis: Resident-Driven Graduate Medical Education at a Military Training Facility during the COVID-19 Pandemic.

Authors:  Donovan S Reed; Marshall D Hill; Grant A Justin; Gregory B Giles; Joseph A Santamaria; Samuel D Hobbs; Brett W Davies; Gary L Legault
Journal:  Mil Med       Date:  2020-12-30       Impact factor: 1.437

2.  Telemedicine in Otolaryngology in the COVID-19 Era: Initial Lessons Learned.

Authors:  Jason F Ohlstein; Jordan Garner; Masayoshi Takashima
Journal:  Laryngoscope       Date:  2020-08-31       Impact factor: 2.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.